OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Leon Thal

1 Projects | 1 Researchers | $399,891 Invested

1999

University of California, San Diego

Leon Thal, MD

Utility of MRI to Predict Progression from MCI to AD and Treatment Response to Vitamin E and Donepezil

  • Funding Amount: $399,891
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed